FDA Inspection 1112129 — LifeShare Blood Center

LifeShare Blood Center — FEI 3001632629

The FDA completed an inspection of LifeShare Blood Center on November 19, 2019 in Bossier City, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 19, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bossier City, LA (United States)